BioCentury
ARTICLE | Company News

Cephalon, MDS deal

January 13, 2003 8:00 AM UTC

CEPH will use MDS subsidiary MDS Proteomics Inc.’s differential analysis, chemiproteomics, PhosMap phosphorylation fingerprinting and protein interaction mapping technologies in its small molecule dev...